PubRank

G C Viberti

Author PubWeight™ 105.80‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982 6.93
2 Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 1995 4.06
3 Effect of control of blood glucose on urinary excretion of albumin and beta2 microglobulin in insulin-dependent diabetes. N Engl J Med 1979 2.87
4 Continuous subcutaneous insulin infusion in the treatment of diabetes mellitus. Diabetes Care 1980 1.92
5 Microalbuminuria predicts mortality in non-insulin-dependent diabetics. Diabet Med 1984 1.90
6 Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes? BMJ 1993 1.58
7 Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism 1983 1.56
8 Glomerular hyperfiltration as a risk factor for diabetic nephropathy: five-year report of a prospective study. Diabetologia 1991 1.55
9 Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet 1989 1.55
10 Increased glomerular permeability to albumin induced by exercise in diabetic subjects. Diabetologia 1978 1.51
11 Hypomagnesaemia in IDDM patients with microalbuminuria and clinical proteinuria. Diabetologia 1994 1.50
12 Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study. Kidney Int 1992 1.47
13 Safety of continuous subcutaneous insulin infusion: metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion. Diabetologia 1982 1.46
14 Multicenter evaluation of the Micral-Test II test strip, an immunologic rapid test for the detection of microalbuminuria. Diabetes Care 1997 1.45
15 Serum leptin concentration in moderate and severe obesity: relationship with clinical, anthropometric and metabolic factors. Int J Obes Relat Metab Disord 1999 1.39
16 A man with diabetes and unexplained renal failure. Lancet 1998 1.39
17 Long term correction of hyperglycaemia and progression of renal failure in insulin dependent diabetes. Br Med J (Clin Res Ed) 1983 1.31
18 Microalbuminuria in non-insulin-dependent diabetes: its prevalence in Indian compared with Europid patients. Br Med J (Clin Res Ed) 1988 1.29
19 Monitoring glomerular function in diabetic nephropathy. A prospective study. Am J Med 1983 1.25
20 Human insulin produced by recombinant DNA technology: safety and hypoglycaemic potency in healthy men. Lancet 1980 1.24
21 Blood pressure, retinopathy and urinary albumin excretion in IDDM: the EURODIAB IDDM Complications Study. Diabetologia 1995 1.22
22 Subclinical hypothyroidism in obese patients: relation to resting energy expenditure, serum leptin, body composition, and lipid profile. Obes Res 2001 1.22
23 Genesis and evolution of diabetic nephropathy. J Clin Pathol 1981 1.21
24 Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia 1996 1.21
25 The variability of overnight urinary albumin excretion in insulin-dependent diabetic and normal subjects. Diabet Med 1987 1.19
26 Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci (Lond) 1993 1.16
27 Metabolic syndrome in obese Caucasian children: prevalence using WHO-derived criteria and association with nontraditional cardiovascular risk factors. Int J Obes (Lond) 2006 1.13
28 Urinary excretion of albumin in normal man: the effect of water loading. Scand J Clin Lab Invest 1982 1.13
29 Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria. BMJ 1989 1.13
30 Proteinuria in diabetes mellitus: role of spontaneous and experimental variation of glycemia. Kidney Int 1982 1.07
31 Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes 2000 1.07
32 Proteinuria in diabetes. Diabetologia 1983 1.07
33 Coronary heart disease and urinary albumin excretion rate in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1988 1.04
34 Microalbuminuria as prediction of nephropathy in diabetics. Lancet 1982 1.02
35 Glomerular epithelial foot processes and filtration slits in IDDM patients. Diabetologia 1995 1.00
36 Leptin plasma concentrations are dependent on body fat distribution in obese patients. Int J Obes Relat Metab Disord 2000 0.98
37 Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension: results of a randomized controlled trial. Diabetes Care 2000 0.97
38 Mechanical stretch-induced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen-activated protein kinase-dependent. Diabetes 2000 0.95
39 Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study. Diabetologia 2009 0.95
40 Dietary composition and renal function in healthy subjects. Nephron 1987 0.94
41 Beta 2-microglobulinaemia: a sensitive index of diminishing renal function in diabetics. Br Med J (Clin Res Ed) 1981 0.93
42 Familial, hemodynamic and metabolic factors in the predisposition to diabetic kidney disease. Kidney Int 1994 0.92
43 Diabetic nephropathy. Br Med Bull 1989 0.91
44 Determinants of elevated urinary albumin in the 4,937 type 2 diabetic subjects recruited for the DIABHYCAR Study in Western Europe and North Africa. Diabetes Care 2000 0.91
45 Multiple lipoprotein abnormalities in type I diabetic patients with renal disease. Diabetes 1996 0.91
46 Increased capillary permeability in diabetes mellitus and its relationship to microvascular angiopathy. Am J Med 1983 0.87
47 Neovascularization at the vascular pole region in diabetic glomerulopathy. Nephrol Dial Transplant 1999 0.87
48 The Decorin gene 179 allelic variant is associated with a slower progression of renal disease in patients with type 1 diabetes. Nephron 2002 0.87
49 Eight-month correction of hyperglycemia in insulin-dependent diabetes mellitus is associated with a significant and sustained reduction of urinary albumin excretion rates in patients with microalbuminuria. Diabetes 1985 0.87
50 Plasma renin activity in insulin-dependent diabetics with raised glomerular filtration rate. Clin Endocrinol (Oxf) 1984 0.86
51 Genetic association analyses of non-synonymous single nucleotide polymorphisms in diabetic nephropathy. Diabetologia 2008 0.86
52 Early functional and morphological changes in diabetic nephropathy. Clin Nephrol 1979 0.85
53 Biosynthetic human insulin: progress and prospects. Diabetes Care 1981 0.85
54 Threshold effect of plasma glucose in the glomerular hyperfiltration of diabetes. Nephron 1984 0.84
55 Promoters of progression of diabetic nephropathy: the relative roles of blood glucose and blood pressure control. Nephrol Dial Transplant 1997 0.84
56 P38 mitogen-activated protein kinase mediates hexosamine-induced TGFbeta1 mRNA expression in human mesangial cells. Diabetologia 2003 0.84
57 Plasma insulin and C-peptide after subcutaneous and intravenous administration of human insulin (recombinant DNA) and purified porcine insulin in healthy men. Diabetes Care 1987 0.84
58 Storage temperature and differing methods of sample preparation in the measurement of urinary albumin. Diabetologia 1993 0.84
59 Detection of potentially reversible diabetic albuminuria. A three-drop agglutination test for urinary albumin at low concentration. Diabetes 1982 0.83
60 Proteinuria and activated T-lymphocytes in diabetic nephropathy. Diabetes 1988 0.83
61 Beta blockade and diabetes mellitus: effect of oxprenolol and metoprolol on the metabolic, cardiovascular, and hormonal response to insulin-induced hypoglycemia in normal subjects. Metabolism 1980 0.82
62 Changes in renal function in response to protein restricted diet in type 1 (insulin-dependent) diabetic patients. Diabetologia 1987 0.81
63 Microalbuminuria as a marker of silent myocardial ischaemia in IDDM patients. Diabetologia 1996 0.81
64 Glucose-induced hyperkalaemia: A hazard for diabetics? Lancet 1978 0.81
65 A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria. Diabetes 2000 0.81
66 Intermittent clinical proteinuria and renal function in diabetes: evolution and the effect of glycaemic control. Br Med J (Clin Res Ed) 1986 0.80
67 Patient reactions to long-term outpatient treatment with continuous subcutaneous insulin infusion. Br Med J (Clin Res Ed) 1981 0.80
68 Dietary protein and the diabetic kidney. Diabet Med 1987 0.80
69 High prevalence of risk factors for cardiovascular disease in parents of IDDM patients with albuminuria. Diabetologia 1997 0.80
70 ACE, PAI-1, decorin and Werner helicase genes are not associated with the development of renal disease in European patients with type 1 diabetes. Diabetes Metab Res Rev 1999 0.78
71 LDL subclasses in IDDM patients: relation to diabetic nephropathy. Diabetologia 1994 0.78
72 Effect of selective inhibition of thromboxane synthesis on renal function in diabetic nephropathy. J Lab Clin Med 1993 0.78
73 Effect of metergoline, a specific serotonin antagonist, on human growth hormone response to arginine and L-dopa. Horm Metab Res 1976 0.78
74 Early functional and morphologic vascular renal consequences of the diabetic state. Diabetologia 1980 0.78
75 Comment on: Boden et al. (2007) Combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes: prevention of fluid retention: Diabetes 56:248-255. Diabetes 2007 0.78
76 Stimulatory effect of the dopa-decarboxylase inhibitor Ro 4-4602 on prolactin release; inhibition by l-dopa, metergoline, methysergide and 2-Br-alpha-ergocryptine. Acta Endocrinol (Copenh) 1977 0.78
77 An aid to the early detection and management of diabetic nephropathy: assessment of a new point of care microalbuminuria system in the diabetic clinic. Diabet Med 2001 0.77
78 Beta blockade and diabetes mellitus: effect of oxprenolol and metoprolol on the metabolic, cardiovascular, and hormonal response to insulin-induced hypoglycemia in insulin-dependent diabetics. Metabolism 1980 0.77
79 Premature cell ageing and evolution of diabetic nephropathy. Diabetologia 1997 0.77
80 Lipoprotein(a) in type 1 diabetic patients with renal disease. Diabet Med 1994 0.77
81 Cardiovascular risk in diabetic kidney disease: a model of chronic renal disease. Kidney Int Suppl 2005 0.77
82 Renal functional response to protein loading in type 1 (insulin-dependent) diabetic patients on normal or high salt intake. Nephron 1997 0.76
83 The effect of fish-oil on the remission of type 1 (insulin-dependent) diabetes in newly diagnosed patients. Diabetologia 1989 0.76
84 Misleading meta-analysis: a need to look beyond the headlines. Diabet Med 2007 0.76
85 Diabetogenic effect of cyclosporin. Br Med J (Clin Res Ed) 1987 0.76
86 Blood rheology and cardiovascular risk factors in type 1 diabetes: relationship with microalbuminuria. Diabet Med 1991 0.76
87 QT dispersion in microalbuminuric Type 1 diabetic patients without myocardial ischemia. J Diabetes Complications 2001 0.76
88 Glucose-induced changes in renal haemodynamics in proteinuric type 1 (insulin-dependent) diabetic patients: inhibition by acetylsalicilic acid infusion. Diabetologia 1993 0.76
89 Severe diabetic microangiopathy with normal glucose tolerance and pituitary infarction. Br Med J (Clin Res Ed) 1983 0.75
90 Glycaemic control in diabetic nephropathy. Br Med J (Clin Res Ed) 1984 0.75
91 The kidney in diabetes: significance of the early abnormalities. Clin Endocrinol Metab 1986 0.75
92 Selective and extremely long inhibition of prolactin release in man by 1-ethyl-3-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'-beta- carbonyl)-urea-diphosphate (FCE 21336). Br J Clin Pharmacol 1987 0.75
93 Predictive value of microalbuminuria in longstanding insulin dependent diabetes. BMJ 1993 0.75
94 Searching for new coronary heart disease risk factors. Eur Heart J 2000 0.75
95 -to: Ong KK, Petry CJ, Emmett PM et al.; ALSPAC study team (2004) Insulin sensitivity and secretion in normal children related to size at birth, postnatal growth, and plasma insulin-like growth factor-I levels. Diabetologia 47:1064-1070. Diabetologia 2004 0.75
96 Does "afternoon diabetes" predict diabetes? Br Med J 1978 0.75
97 Monitoring kidney function in diabetic nephropathy. Diabetologia 1995 0.75
98 Prevalence of hypertension in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1991 0.75
99 Role of insulin-like growth factor (IGF)-1 in the modulation of renal haemodynamics in Type I diabetic patients. Diabetologia 2000 0.75
100 Metabolic effects of physical exercise in insulin-dependent diabetics controlled by continuous subcutaneous insulin infusion or conventional injection therapy. Acta Endocrinol (Copenh) 1984 0.75
101 Strategies for the prevention of diabetic kidney disease: early antihypertensive treatment or improved glycemic control? J Diabetes Complications 1994 0.75
102 Effect of metergoline, a powerful and long-acting antiserotoninergic agent, on insulin secretion in normal subjects and in patients with chemical diabetes. Diabetologia 1975 0.75
103 Predicting diabetic nephropathy. N Engl J Med 1984 0.75
104 Lipoprotein(a) and atherosclerotic disease in insulin-dependent diabetic patients with declining glomerular filtration rate. Diabet Med 1996 0.75
105 Lack of evidence for the 1484insG variant at the 3'-UTR of the protein tyrosine phosphatase 1B (PTP1B) gene as a genetic determinant of diabetic nephropathy development in type 1 diabetic patients. Nephrol Dial Transplant 2004 0.75
106 Rapid detection of urinary albumin at low concentration by an agglutination inhibition techniqué. Diabet Med 1987 0.75
107 Revised vs original QUICKI index during diet + rosiglitazone treatment in obese subjects. Diabetes Metab 2004 0.75
108 Prevention of diabetic nephropathy: markers of disease and perspectives for intervention. Diabet Med 1986 0.75
109 [Can diabetic nephropathy be prevented?]. Journ Annu Diabetol Hotel Dieu 1983 0.75
110 The effect of glycaemic control on the early abnormalities of the diabetic kidney. Minerva Nefrol 1983 0.75
111 Risk of nephropathy in diabetes mellitus: problems of methodology and terminology. Diabetologia 1985 0.75
112 Effect of beta-blocker therapy on serum lipoprotein profiles in patients on renal dialysis and in diabetic nephropathy. Diabetes Res 1993 0.75
113 Renal response to restricted protein intake in diabetic nephropathy. Diabetes 1988 0.75
114 Microalbuminuria and diabetes. Lancet 1983 0.75
115 Bedside estimation of microalbuminuria. Lancet 1986 0.75
116 Antibodies to human albumin epitopes in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1988 0.75
117 Fluorescein angiography in borderline diabetics. Diabete Metab 1979 0.75
118 Patterns of hyperinsulinaemia in type 1 diabetic patients with and without nephropathy. Diabet Med 1989 0.75
119 Sodium-lithium countertransport activity as a determinant of deterioration of glomerular function in IgA nephropathy. Exp Nephrol 1994 0.75
120 Low-protein diet and progression of renal disease in diabetic nephropathy. Lancet 1990 0.75
121 Is it possible to predict diabetic kidney disease? J Endocrinol Invest 2000 0.75
122 The influence of glucose-induced hyperinsulinaemia on renal glomerular function and circulating catecholamines in normal man. Diabetologia 1981 0.75
123 Aspects of continuous subcutaneous insulin infusion (CSII) in diabetes. Diabetes Care 1981 0.75
124 Clinical application of pre-programmed insulin infusion: continuous subcutaneous insulin therapy with a portable infusion system. Horm Metab Res Suppl 1979 0.75
125 Effect of low protein diet on the renal response to meat ingestion in diabetic nephropathy. Eur J Clin Invest 1991 0.75
126 Proteinuria in diabetes. J R Coll Physicians Lond 2001 0.75
127 Biosynthetic human insulin: effect in healthy men on plasma glucose and non-esterified fatty acids in comparison with highly purified pork insulin. Diabetes Care 1981 0.75
128 Modelling and costing the consequences of using an ACE inhibitor to slow the progression of renal failure in type I diabetic patients. QJM 1997 0.75
129 The glomerular hyperfiltration of diabetes is not associated with elevated plasma levels of glucagon and growth hormone. Diabetologia 1985 0.75
130 Creatinine is a poor marker of renal failure. Diabet Med 1985 0.75
131 Proteinuria and diabetic control in insulin-dependent diabetes mellitus. Acta Endocrinol Suppl (Copenh) 1981 0.75
132 Kidney size and glomerular filtration rate in Type 1 (insulin-dependent) diabetes mellitus revisited. Diabetologia 1983 0.75
133 Hypertension and microalbuminuria as predictors of diabetic nephropathy. Diabete Metab 1989 0.75